Multifunctional Polymeric Nanosystems for Dual-Targeted Combinatorial Chemo/Antiangiogenesis Therapy of Tumors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multifunctional Polymeric Nanosystems for Dual-Targeted Combinatorial Chemo/Antiangiogenesis Therapy of Tumors
Authors
Keywords
-
Journal
Advanced Healthcare Materials
Volume 5, Issue 12, Pages 1447-1461
Publisher
Wiley
Online
2016-05-01
DOI
10.1002/adhm.201600169
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sigma receptor-mediated targeted delivery of anti-angiogenic multifunctional nanodrugs for combination tumor therapy
- (2016) Yuanke Li et al. JOURNAL OF CONTROLLED RELEASE
- Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region
- (2015) Mohamadreza Amin et al. JOURNAL OF CONTROLLED RELEASE
- Heparin-Engineered Mesoporous Iron Metal-Organic Framework Nanoparticles: Toward Stealth Drug Nanocarriers
- (2015) Elena Bellido et al. Advanced Healthcare Materials
- Intracellular Tracking of Single Native Molecules with Electroporation-Delivered Quantum Dots
- (2014) Chen Sun et al. ANALYTICAL CHEMISTRY
- Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells
- (2014) Fei Wang et al. CANCER SCIENCE
- Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase
- (2014) Dongzhu Duan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid
- (2014) Jing Yao et al. International Journal of Nanomedicine
- Versatile Reticular Polyethylenimine Derivative-Mediated Targeted Drug and Gene Codelivery for Tumor Therapy
- (2014) Xuefang Ding et al. MOLECULAR PHARMACEUTICS
- Tumor-Targeting and Microenvironment-Responsive Smart Nanoparticles for Combination Therapy of Antiangiogenesis and Apoptosis
- (2013) Shixian Huang et al. ACS Nano
- Autophagy Inhibition Promotes Gambogic Acid-induced Suppression of Growth and Apoptosis in Glioblastoma Cells
- (2013) Guo-Xuan Luo et al. Asian Pacific Journal of Cancer Prevention
- CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels
- (2013) Quanyin Hu et al. BIOMATERIALS
- Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment
- (2013) Huile Gao et al. BIOMATERIALS
- Gambogic acid inhibits angiogenesis through inhibiting PHD2–VHL–HIF-1α pathway
- (2013) Na Lu et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
- (2012) Nora Graf et al. ACS Nano
- Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system
- (2012) Lin Hou et al. BIOMATERIALS
- Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic charge
- (2012) Seung Woo Chung et al. BIOMATERIALS
- Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor
- (2012) Asarasin Adulnirath et al. JOURNAL OF CONTROLLED RELEASE
- RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
- (2012) Fabienne Danhier et al. MOLECULAR PHARMACEUTICS
- PEG prodrug of gambogic acid: Amino acid and dipeptide spacer effects
- (2012) Ya Ding et al. POLYMER
- Integrin Targeted Delivery of Chemotherapeutics
- (2012) Kai Chen et al. Theranostics
- Low molecular weight heparin-all-trans-retinoid acid conjugate as a drug carrier for combination cancer chemotherapy of paclitaxel and all-trans-retinoid acid
- (2011) Lin Hou et al. CARBOHYDRATE POLYMERS
- Tumor Specific Delivery and Therapy by Double-Targeted Nanostructured Lipid Carriers with Anti-VEGFR-2 Antibody
- (2011) Donghua Liu et al. MOLECULAR PHARMACEUTICS
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Heparin immobilized gold nanoparticles for targeted detection and apoptotic death of metastatic cancer cells
- (2010) Kyuri Lee et al. BIOMATERIALS
- Artificial oxygen carrier based on polysaccharides–poly(alkylcyanoacrylates) nanoparticle templates
- (2010) Cédric Chauvierre et al. BIOMATERIALS
- Studies on chemical modification and biology of a natural product, gambogic acid (II): Synthesis and bioevaluation of gambogellic acid and its derivatives from gambogic acid as antitumor agents
- (2010) Jinxin Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives
- (2010) Jin Woo Park et al. JOURNAL OF CONTROLLED RELEASE
- Strategies in the design of nanoparticles for therapeutic applications
- (2010) Robby A. Petros et al. NATURE REVIEWS DRUG DISCOVERY
- Nanoparticulate Delivery System Targeted to Tumor Neovasculature for Combined Anticancer and Antiangiogenesis Therapy
- (2010) Zhe Wang et al. PHARMACEUTICAL RESEARCH
- A Double Hit to Kill Tumor and Endothelial Cells by TRAIL and Antiangiogenic 3TSR
- (2009) B. Ren et al. CANCER RESEARCH
- General pharmacological properties, developmental toxicity, and analgesic activity of gambogic acid, a novel natural anticancer agent
- (2009) Li Zhao et al. DRUG AND CHEMICAL TOXICOLOGY
- HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity
- (2009) Tomáš Etrych et al. JOURNAL OF CONTROLLED RELEASE
- Polymer-drug conjugates: Recent development in clinical oncology
- (2008) Chun Li et al. ADVANCED DRUG DELIVERY REVIEWS
- Synthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell death
- (2008) Ki Hyun Bae et al. BIOMATERIALS
- Gambogic Acid Inhibits Angiogenesis and Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2 Signaling
- (2008) T. Yi et al. CANCER RESEARCH
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- Addition of Bevacizumab to Fluorouracil-Based First-Line Treatment of Metastatic Colorectal Cancer: Pooled Analysis of Cohorts of Older Patients From Two Randomized Clinical Trials
- (2008) Fairooz F. Kabbinavar et al. JOURNAL OF CLINICAL ONCOLOGY
- Studies on the toxicity of gambogic acid in rats
- (2008) Qi Qi et al. JOURNAL OF ETHNOPHARMACOLOGY
- Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins
- (2008) Dayong Zhai et al. MOLECULAR CANCER THERAPEUTICS
- Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells
- (2008) Hongyan Gu et al. MOLECULAR CANCER THERAPEUTICS
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
- (2008) Frank Alexis et al. MOLECULAR PHARMACEUTICS
- Tumor Endothelial Cell Targeted Cyclic RGD-modified Heparin Derivative: Inhibition of Angiogenesis and Tumor Growth
- (2008) Kyeongsoon Park et al. PHARMACEUTICAL RESEARCH
- Inhibition of glioblastoma growth and angiogenesis by gambogic acid: An in vitro and in vivo study
- (2007) Lei Qiang et al. BIOCHEMICAL PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started